National Company Law Tribunal approved Scheme of Amalgamation of wholly-owned subsidiary Shilpa Therapeutics with Shilpa Medicare.
Simplifies corporate structure through subsidiary merger. Approval received on March 6, 2026.
*Business event analysis, not a stock prediction.